Navigation Links
State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications
Date:6/15/2012

OSLO, Norway, June 15, 2012 /PRNewswire/ -- The Novelda NVA6000 series Impulse Radar transceivers are cutting-edge radar transceivers that incorporate extremely high frame rate and accuracy, in addition to unique penetration capabilities. Integrated on a single chip, this radar transceiver transmits pulses of high bandwidth.

In comparison to traditional technology, the Novelda NVA6000 Impulse Radar transceiver offers several improvements and value added features.

The ability to detect objects behind obstacles, coupled with increased speed and high sensitivity, not only makes it complementary and/or a substitute for existing technologies such as ultrasound, video and infrared sensors, but it has catered to new areas of applications as well.

The Novelda Impulse Radar transceiver successfully caters to sensor applications across a range of sectors including health monitoring (including stress and pulse monitoring), medical diagnosis (including heart beat monitoring and 3D RF-imaging), automotive and industrial (including distance and road obstacle detection), security surveillance (such as motion detection), and energy automation and defense.

"Unlike technologies that demand free visibility, Novelda NVA6000 Impulse Radar transceiver's ability to detect objects behind obstacles eliminates the need to clean lenses, thus ensuring cost savings for customers," concludes Novelda's CMO Aage Kalsaeg. "In addition, Novelda saves costs and time for developers by supplying development kits, radar modules and software, and providing development support for the entire range of available chips."

Please visit http://www.novelda.no/content/application-ideas for application examples and ideas.

ABOUT NOVELDA AS

Novelda AS is a privately held, R&D driven semiconductor company based in Norway and specializing in nanoscale wireless low-power technology for ultra-high resolution impulse radar.

Novelda was founded in 2004 as a spin-out from the University of Oslo, and there is a strong Research & Development partnership with the university. www.novelda.no

High-resolution images:

Novelda Development Kit with Sinuous antennas:
http://www.novelda.no/sites/default/files/images/products/NewDevelopmentKit.jpg

Novelda NVA6000 series Nanoscale Impulse Radar Chips:
http://www.novelda.no/sites/default/files/images/products/web-large/NVA6x00-Chips-and-Match.jpg

Press Release Contact: Aage Kalsaeg; aage(at)novelda.no

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Novelda AS
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
2. U Alberta finds weakness in armor of killer hospital bacteria
3. Study In Prenatal Diagnosis Finds Sequenom CMMs MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
4. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
5. Study finds chronic abnormal brain blood flow in Gulf War veterans
6. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
7. Global Markets for Enzymes in Industrial Applications
8. TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
9. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
10. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
11. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):